Estamos no ar no ! Saiba mais

Intuitive Surgical

ISRG

Valor de mercado US$ 151 bi

426,70 USD

-1,16

0,27%

No fechamento Atualizado 16 de out. 16:00 EDT

Pré-mercado

Após o fechamento do mercado

423,00

-3,70

0,87%

1 dia

-0,27%

5 dias

0,87%

1 mês

11,62%

3 meses

6,06%

6 meses

-6,85%

No acumulado do ano

-24,07%

1 ano

-1,82%

5 anos

28,41%

10 anos

441,29%

Sobre: Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 11,000 da Vinci systems in hospitals worldwide, with more than 6,600 installations in the US and a growing number in emerging markets.

Funcionários: 17.021

Saúde Instrumentos e suprimentos médicos

Notícias

Positivo

Neutro

Negativo

Sentimento 3 meses

Positivo 59%

Neutro 27%

Negativo 14%

The Motley Fool

Intuitive Surgical (ISRG) Stock Is Down 25% Year to Date. History Says Patient Investors Get Rewarded.

Intuitive Surgical is a dominant force in robotic surgery systems. It makes most of its money from selling servicing and supplies.

Intuitive Surgical (ISRG) Stock Is Down 25% Year to Date. History Says Patient Investors Get Rewarded.

Zacks Investment Research

Forget AI Stocks: Buy Med-Tech Stock ISRG Now for 40% Upside

Intuitive Surgical stock earns a Zacks Rank #2 (Buy) and looks poised for a potential technical breakout as it overtakes vital long-term levels heading into its Q3 earnings release on October 20.

Forget AI Stocks: Buy Med-Tech Stock ISRG Now for 40% Upside

Zacks Investment Research

First Week of Q3 Earnings in the Books

The Dow looks to close higher for its second-straight week, while the Nasdaq hopes to avoid its worst trading week since July.

First Week of Q3 Earnings in the Books

Zacks Investment Research

ISRG Ahead of Q3 Earnings: Can Procedure Growth Sustain Momentum?

Intuitive Surgical's Q3 earnings hinge on robotic surgery growth, system demand and margins amid slowing US procedures, China headwinds and premium valuation.

ISRG Ahead of Q3 Earnings: Can Procedure Growth Sustain Momentum?

Zacks Investment Research

Intuitive Surgical, Inc. (ISRG) Beats Stock Market Upswing: What Investors Need to Know

Intuitive Surgical, Inc. (ISRG) reached $427.86 at the closing of the latest trading day, reflecting a +1.81% change compared to its last close.

Intuitive Surgical, Inc. (ISRG) Beats Stock Market Upswing: What Investors Need to Know

Zacks Investment Research

Countdown to Intuitive Surgical (ISRG) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS

Evaluate the expected performance of Intuitive Surgical (ISRG) for the quarter ended September 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Countdown to Intuitive Surgical (ISRG) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS

Zacks Investment Research

ISRG Gains Nearly 12% in a Month: Should You Buy, Hold or Sell?

Intuitive Surgical shares have surged nearly 12% in a month ahead of Q3 earnings. Strong da Vinci 5 adoption and Ion growth fuel momentum, but valuation and risks linger.

ISRG Gains Nearly 12% in a Month: Should You Buy, Hold or Sell?

Zacks Investment Research

ISRG Is Expanding Beyond Surgery: Here's Why the GI Opportunity Matters

Intuitive Surgical is targeting GI care with a next-generation robotic endoscope submitted to the FDA, opening a potential growth avenue beyond surgery.

ISRG Is Expanding Beyond Surgery: Here's Why the GI Opportunity Matters

Zacks Investment Research

Intuitive Surgical (ISRG) Upgraded to Buy: Here's Why

Intuitive Surgical (ISRG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Intuitive Surgical (ISRG) Upgraded to Buy: Here's Why

Zacks Investment Research

3 Sales Growth Stocks to Buy as Q3 Earnings Get Underway

Chipotle, BP and Intuitive Surgical stand out for strong sales growth, solid cash flow and favorable valuation metrics as Q3 earnings begin.

3 Sales Growth Stocks to Buy as Q3 Earnings Get Underway

Ver ranking de notícias

Gráficos de preços implementados com Lightweight Charts™